mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0008 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.001 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.002 |